The efficacy of DIQUAS ophthalmic solution 3% for dry eye patients before cataract surgery

The efficacy of DIQUAS ophthalmic solution 3% for dry eye patients before cataract surgery - The efficacy of DIQUAS ophthalmic solution 3% for dry eye patients before cataract surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029333

Enrollment

120

Registered

2017-10-02

Start date

2017-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Diquafosol Ophthalmic Solution 3% Artificial tear Mytear ophthalmic solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To have a plan to be given a cataract surgery.

Exclusion criteria

Exclusion criteria: Being on dry eye medication. Using contact lens. Having an infection eye disease. Having a complication of an eye disease which might have an influence on evaluation of this study. Having a history of an allergic reaction to the ingredients used in this study.

Design outcomes

Primary

Measure	Time frame
Dry eye examination results, corneal curvature radius, refraction data and adverse event	—

Countries

Japan

Contacts

Public ContactYoshiaki Yamada

Santen Pharmaceutical Co., Ltd. Japan Medical Affairs group, Development Management Department, Japan Business

clinical@santen.co.jp06-4802-9604

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026